SLC28A2 and hyperuricemia: Since CNT2 is the primary transporter for purine nucleosides during intestinal absorption and transport, inhibiting CNT2 can reduce gastrointestinal absorption of purines, thereby helping to prevent and manage hyperuricemia (Hiratochi et al., 2012).